Private equity firm Lyceum Capital is nearing a sale of Synexus, a UK clinical trials specialist it acquired for £18m in 2007, to peer LDC for £100m.
PressDigest
LDC nears £100m takeover of UK clinical trials firm
Private equity firm Lyceum Capital is nearing a sale of Synexus, a UK clinical trials specialist it acquired for £18m in 2007, to peer LDC for £100m.